Mail

UK markets close in 2 hours 5 minutes

FTSE 100
8,279.53
+41.81(+0.51%)
FTSE 250
20,540.63
+98.28(+0.48%)
AIM
772.62
+0.05(+0.01%)
GBP/EUR
1.1804
-0.0018(-0.15%)
GBP/USD
1.2676
+0.0031(+0.24%)
Bitcoin GBP
48,170.87
-2,526.70(-4.98%)

How to invest in artificial intelligence

AI stocks are continuing to rally but what should you buy?

Xvivo Perfusion AB (publ) (XVIVOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK

Add to watchlist

320.75

0.00

(0.00%)

As of 08:56AM BST. Market open.

Currency in SEK

Valuation measures⁴

Market cap (intra-day)	13.34B
Enterprise value	12.86B
Trailing P/E	352.47
Forward P/E	74.07
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	18.20
Price/book (mrq)	6.72
Enterprise value/revenue	14.68
Enterprise value/EBITDA	263.45

Trading information

Stock price history

Beta (5Y monthly)	2.06
52-week change ³	12.35%
S&P500 52-week change ³	26.24%
52-week high ³	320.75
52-week low ³	285.50
50-day moving average ³	320.75
200-day moving average ³	320.75

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	31.5M
Implied shares outstanding ⁶	31.5M
Float ⁸	25M
% held by insiders ¹	10.48%
% held by institutions ¹	59.64%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	15.62%
Operating margin (ttm)	10.21%

Management effectiveness

Return on assets (ttm)	0.41%
Return on equity (ttm)	5.82%

Income statement

Revenue (ttm)	642.95M
Revenue per share (ttm)	21.18
Quarterly revenue growth (yoy)	32.30%
Gross profit (ttm)	N/A
EBITDA	31.13M
Net income avi to common (ttm)	100.43M
Diluted EPS (ttm)	0.90
Quarterly earnings growth (yoy)	60.70%

Balance sheet

Total cash (mrq)	511.15M
Total cash per share (mrq)	16.23
Total debt (mrq)	30.91M
Total debt/equity (mrq)	1.54%
Current ratio (mrq)	4.16
Book value per share (mrq)	63.59

Cash flow statement

Operating cash flow (ttm)	60.3M
Levered free cash flow (ttm)	-90.84M